BioSpace News Archive

USA News Group - Oncology data leader COTA recently released a recent survey where half of the respondents pointed to “Operation Warp Speed” as evidence that cancer treatments can and should be moving forward faster.

NEOGEN Corporation (NASDAQ: NEOG) announced today that it has acquired Atlanta -based CAPInnoVet, Inc., a companion animal health company that provides pet medications to the veterinary market.

For more information regarding the conferences, or to schedule a one-on-one meeting with Awakn’s management team, please contact your conference representative or KCSA Strategic Communications at Awakn@KCSA.com directly.

Jasper Therapeutics, Inc. and Amplitude Healthcare Acquisition Corporation announced that Lawrence Klein, Ph.D., and Chris Nolet will be appointed to Jasper Therapeutics’ board of directors, effective upon closing of the pending merger between the parties.

Gemina Laboratories Ltd. is pleased to provide an update on its current activities related to the development of its first rapid diagnostic test targeting the SARS CoV-2 antigen, using the Company’s patented breakthrough chemistry.

Galapagos issued 7,600 new ordinary shares on 20 September 2021, for a total capital increase of €151,787.50.

INmune Bio, Inc. (NASDAQ: INMB) (the “Company”), a clinical-stage immunology company focused on developing treatments that harness the patient’s innate immune system to fight disease, today announced that Raymond J. Tesi, MD, President and CEO, is scheduled to participate in two upcoming investor conferences in September 2021.

Pacific Biosciences of California, Inc. announced today the companies have closed the transaction under which Pacific Biosciences acquired Omniome.

Femasys Inc., a biomedical company developing a suite of product candidates to transform women’s healthcare with minimally invasive, non-surgical, in-office technologies, announced that the Company has been added to the Russell Microcap® Index when the U.S. market opened.

Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies and cytokines for the treatment of cancer and autoimmune diseases, today announced that company management will present at the Cantor Virtual Global Healthcare Conference